KATHERINE PETTYJOHN: Open Payments
NPI 1568945285 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 14 payments from 6 companies in 2025. Trend: 2023 $546 · 2024 $492 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $532 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| Novo Nordisk Inc | 1 | $93 |
| ABIOMED | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: TEZSPIRE, BREZTRI, XIFAXAN, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
